Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Marius Bill, PhD, Madlen Jentzsch, MD, Thoralf Lange, MD, Laura Kloss, Rainer Krahl, PhD, Georg Franke, MD, Stephan Fricke, MD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Haifa Kathrin Al-Ali, MD, Gerhard Behre, MD, Michael Cross, PhD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2013) 122 (21): 3383.

https://doi.org/10.1182/blood.V122.21.3383.3383

Published: 2013

Journal Articles

Outcome Of MDS and AML With MDS-Related Changes: Treatment Versus Prognostic Factors

Nadja Jaekel, Susann Schulze, Cora Graneist, Rainer Krahl, PhD, Wolfram Poenisch, MD, Thoralf Lange, Vladan Vucinic, MD, Georg Franke, MD, Christian Pfrepper, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD

Blood (2013) 122 (21): 5223.

https://doi.org/10.1182/blood.V122.21.5223.5223

Published: 2013

Journal Articles

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Dietger Niederwieser, MD, Leo F Verdonck, Jan J Cornelissen, MD PhD, Michael Cross, PhD, Rainer Krahl, MD, Thoralf Lange, Vladan Vucinic, Georg Franke, MD, Haifa K. Al-Ali, MD, Gert Ossenkoppele, MD, PhD, Georg Maschmeyer, MD, Gottfried Doelken, MD, Mathias Freund, MD, Norma Peter, Marc Boogaerts, MD, PhD, Alois Gratwohl, MD, Harry C. Schouten, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2011) 118 (21): 2030.

https://doi.org/10.1182/blood.V118.21.2030.2030

Published: 2011

Journal Articles

Hematopoietic Cell Transplantation After Reduced Intensity Conditioning for Severe Paroxysmal Nocturnal Hemoglobinuria:

Rafic Farah, Georg Franke, MD, Tara B. Gregory, MD, Mark W. Brunvand, MD, Thoralf Lange, Rainer Storb, MD, Robert P. Witherspoon

Blood (2011) 118 (21): 2047.

https://doi.org/10.1182/blood.V118.21.2047.2047

Published: 2011

Journal Articles

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Claudia Nehring, Cornelia Becker, MD, Leanthe Braunert, MD, Sabine Leiblein, Jeanett Edelmann, Georg Franke, MD, Wolfram Poenisch, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2011) 118 (21): 3065.

https://doi.org/10.1182/blood.V118.21.3065.3065

Published: 2011

Journal Articles

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Total Body Irradiation (3 or 4 Gy) after Failure of First Allografts.

Boglarka Gyurkocza, MD, Thai M. Cao, MD, Rainer F. Storb, MD, Thoralf Lange, MD, Wendy Leisenring, Sc.D., Georg Franke, MD, Mohamed L. Sorror, MD, MS, David G. Maloney, MD, PhD, Judith Shizuru, MD, PhD, Brenda M. Sandmaier, MD

Blood (2008) 112 (11): 3272.

https://doi.org/10.1182/blood.V112.11.3272.3272

Published: 2008

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

Blood (2008) 112 (11): 2162.

https://doi.org/10.1182/blood.V112.11.2162.2162

Published: 2008

Journal Articles

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Max Hubmann, Ralph Burkhardt, Georg Franke, Michael Cross, Markus Scholz, Sabine Leiblein, Joachim Thiery, Dietger W. Niederwieser, Thoralf Lange

Blood (2006) 108 (11): 548.

https://doi.org/10.1182/blood.V108.11.548.548

Published: 2006

NARROW

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Outcome Of MDS and AML With MDS-Related Changes: Treatment Versus Prognostic Factors

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Hematopoietic Cell Transplantation After Reduced Intensity Conditioning for Severe Paroxysmal Nocturnal Hemoglobinuria:

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Total Body Irradiation (3 or 4 Gy) after Failure of First Allografts.

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only